Skip to main content

A panelist discusses the use of dual orexin receptor antagonists (DORAs) as a first-line treatment for chronic insomnia due to their efficacy in improving sleep without the risks of dependence or cognitive issues while also noting their effectiveness in patients with psychophysiologic insomnia and the importance of managing patient expectations regarding their use.:

Source: Neurology Read More